|
|
|
|
|
|
|
|
|
|
Previous: DUALSTAR TECHNOLOGIES CORP, 10-K, EX-23.1, 2000-09-28 |
Next: INKINE PHARMACEUTICAL CO INC, 8-K, 2000-09-28 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> YEAR
<FISCAL-YEAR-END> JUN-30-2000
<PERIOD-END> JUN-30-2000
<CASH> 13,823,267
<SECURITIES> 0
<RECEIVABLES> 1,427,856
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 27,561,262
<PP&E> 5,210,383
<DEPRECIATION> 0
<TOTAL-ASSETS> 37,080,412
<CURRENT-LIABILITIES> 10,554,273
<BONDS> 0
0
0
<COMMON> 164,766
<OTHER-SE> 0
<TOTAL-LIABILITY-AND-EQUITY> 37,080,412
<SALES> 5,256,899
<TOTAL-REVENUES> 5,256,899
<CGS> 4,253,654
<TOTAL-COSTS> 4,253,654
<OTHER-EXPENSES> 477,023
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 741,603
<INCOME-PRETAX> (7,199,652)
<INCOME-TAX> 68,000
<INCOME-CONTINUING> (7,267,652)
<DISCONTINUED> (1,383,166)
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (8,650,818)
<EPS-BASIC> (0.68)
<EPS-DILUTED> (0.68)
</TABLE>
|
|